AxoGen Inc. (AXGN)
AxoGen Statistics
Share Statistics
AxoGen has 44.34M shares outstanding. The number of shares has increased by 1.46% in one year.
| Shares Outstanding | 44.34M |
| Shares Change (YoY) | 1.46% |
| Shares Change (QoQ) | 0.76% |
| Owned by Institutions (%) | 81.7% |
| Shares Floating | 41.83M |
| Failed to Deliver (FTD) Shares | 4.37K |
| FTD / Avg. Volume | 0.87% |
Short Selling Information
The latest short interest is 1.84M, so 4.15% of the outstanding shares have been sold short.
| Short Interest | 1.84M |
| Short % of Shares Out | 4.15% |
| Short % of Float | 4.91% |
| Short Ratio (days to cover) | 3.08 |
Valuation Ratios
The PE ratio is -73.2 and the forward PE ratio is 31.26. AxoGen's PEG ratio is 1.33.
| PE Ratio | -73.2 |
| Forward PE | 31.26 |
| PS Ratio | 3.89 |
| Forward PS | 1.8 |
| PB Ratio | 7.02 |
| P/FCF Ratio | 66306.16 |
| PEG Ratio | 1.33 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for AxoGen.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.24, with a Debt / Equity ratio of 0.66.
| Current Ratio | 3.24 |
| Quick Ratio | 2.16 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 11.3 |
| Debt / FCF | 6.24K |
| Interest Coverage | -0.4 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $415.38K |
| Profits Per Employee | $-22.09K |
| Employee Count | 451 |
| Asset Turnover | 0.92 |
| Inventory Turnover | 1.37 |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by 148.62% in the last 52 weeks. The beta is 0.99, so AxoGen's price volatility has been higher than the market average.
| Beta | 0.99 |
| 52-Week Price Change | 148.62% |
| 50-Day Moving Average | 17.57 |
| 200-Day Moving Average | 14.67 |
| Relative Strength Index (RSI) | 45.52 |
| Average Volume (20 Days) | 501.9K |
Income Statement
In the last 12 months, AxoGen had revenue of 187.34M and earned -9.96M in profits. Earnings per share was -0.23.
| Revenue | 187.34M |
| Gross Profit | 141.98M |
| Operating Income | -3.29M |
| Net Income | -9.96M |
| EBITDA | 6.08M |
| EBIT | -1.76M |
| Earnings Per Share (EPS) | -0.23 |
Balance Sheet
The company has 27.55M in cash and 68.69M in debt, giving a net cash position of -41.13M.
| Cash & Cash Equivalents | 27.55M |
| Total Debt | 68.69M |
| Net Cash | -41.13M |
| Retained Earnings | -291.26M |
| Total Assets | 203.73M |
| Working Capital | 68.61M |
Cash Flow
In the last 12 months, operating cash flow was 4.54M and capital expenditures -4.52M, giving a free cash flow of 11K.
| Operating Cash Flow | 4.54M |
| Capital Expenditures | -4.52M |
| Free Cash Flow | 11K |
| FCF Per Share | 0 |
Margins
Gross margin is 75.79%, with operating and profit margins of -1.75% and -5.32%.
| Gross Margin | 75.79% |
| Operating Margin | -1.75% |
| Pretax Margin | -5.32% |
| Profit Margin | -5.32% |
| EBITDA Margin | 3.24% |
| EBIT Margin | -1.75% |
| FCF Margin | 0.01% |
Dividends & Yields
AXGN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for AXGN is $26, which is 60.4% higher than the current price. The consensus rating is "Buy".
| Price Target | $26 |
| Price Target Difference | 60.4% |
| Analyst Consensus | Buy |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Jul 11, 1994. It was a forward split with a ratio of 21:20.
| Last Split Date | Jul 11, 1994 |
| Split Type | forward |
| Split Ratio | 21:20 |
Scores
| Altman Z-Score | 3.33 |
| Piotroski F-Score | 4 |